Nisa Investment Advisors’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11K Hold
680
﹤0.01% 2212
2025
Q4
$12.7K Buy
680
+497
+272% +$8.24K ﹤0.01% 2124
2025
Q3
$2.67K Hold
183
﹤0.01% 2560
2025
Q2
$2.02K Hold
183
﹤0.01% 2606
2025
Q1
$1.63K Buy
183
+73
+66% +$679 ﹤0.01% 2520
2024
Q4
$1.03K Hold
110
﹤0.01% 2673
2024
Q3
$887 Buy
110
+4
+4% +$35 ﹤0.01% 2607
2024
Q2
$899 Sell
106
-16
-13% -$144 ﹤0.01% 2544
2024
Q1
$1.09K Buy
122
+82
+205% +$760 ﹤0.01% 2351
2023
Q4
$450 Hold
40
﹤0.01% 2431
2023
Q3
$345 Sell
40
-28
-41% -$270 ﹤0.01% 2593
2023
Q2
$704 Hold
68
﹤0.01% 2493
2023
Q1
$1K Hold
68
﹤0.01% 2458
2022
Q4
$1K Hold
68
﹤0.01% 2510
2022
Q3
$1K Buy
+68
New +$637 ﹤0.01% 2511
2021
Q4
Sell
-7,000
Closed -$52 2320
2021
Q3
$52 Buy
+7,000
New +$78.3K ﹤0.01% 1924
2021
Q2
Sell
-3,800
Closed -$78 2383
2021
Q1
$78 Hold
3,800
﹤0.01% 1860
2020
Q4
$68K Buy
3,800
+113
+3% +$2.03K ﹤0.01% 1896
2020
Q3
$55K Buy
3,687
+3,247
+738% +$60.8K ﹤0.01% 1767
2020
Q2
$9K Sell
440
-4,810
-92% -$124K ﹤0.01% 1942
2020
Q1
$121K Sell
5,250
-160
-3% -$4K ﹤0.01% 1324
2019
Q4
$140K Sell
5,410
-3,090
-36% -$60K ﹤0.01% 1383
2019
Q3
$166K Sell
8,500
-2,699
-24% -$54.5K ﹤0.01% 1367
2019
Q2
$183K Hold
11,199
﹤0.01% 1335
2019
Q1
$254K Buy
+11,199
New +$284K ﹤0.01% 1245

Other funds holding TBPH